Parkinson’s disease is no exception, and the Toll-like receptor 4 signaling pathway involves multiple pathways in pathogenesis studies, starting with the classical Toll-like receptor 4/NF-κB signaling pathway, which is involved in the immune inflammatory response (96, 97). Here, NFKB1 is linked to Parkinson disease.